tldrdailynews.com logo

FDA Approves Moderna's RSV Vaccine for Adults Under 60 Amid Industry Uncertainty

1 min read
Source: ABC News
FDA Approves Moderna's RSV Vaccine for Adults Under 60 Amid Industry Uncertainty
Photo: ABC News
TL;DR

The FDA has expanded Moderna's RSV vaccine approval to include adults under 60 at increased risk, pending CDC advisory committee approval, marking a significant step in protecting more vulnerable populations from severe RSV illness.

Topics:businesshealth#adults-under-60#fda-approval#health#moderna#public-health#rsv-vaccine
Share this article
  1. FDA expands approval of Moderna's RSV vaccine to some adults under age 60  ABC News
  2. Moderna falls on doubts over new CDC panel's backing of RSV vaccine  Reuters
  3. FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains  The Hill
  4. FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59  statnews.com
  5. Moderna Wins Expanded Label for mRNA RSV Shot as New ACIP Members Question mRNA Technology  BioSpace

Want the full story? Read the original reporting

Read on ABC News